ZBIO (Zenas BioPharma) Shares Buyback Ratio % : -5.03 (As of May. 04, 2025)

View and export this data going back to 2024. Start your Free Trial

What is Zenas BioPharma Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Zenas BioPharma's current shares buyback ratio was -5.03%.

Zenas BioPharma Shares Buyback Ratio % Historical Data

The historical data trend for Zenas BioPharma's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zenas BioPharma Shares Buyback Ratio % Chart

Zenas BioPharma Annual Data

Trend

Dec22

Dec23

Dec24

Shares Buyback Ratio %

-208.94

-5.03

Zenas BioPharma Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Shares Buyback Ratio %	Get a 7-Day Free Trial				-128.48	-	-	-5.00	-0.03

Zenas BioPharma Shares Buyback Ratio % Calculation

Zenas BioPharma's Shares Buyback Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(39.792	-	41.793)	/	39.792
	=	-5.03%

Zenas BioPharma's Shares Buyback Ratio for the quarter that ended in Dec. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Sep. 2024 )	-	Shares Outstanding (EOP) (A: Dec. 2024 ))	/	Shares Outstanding (EOP) (A: Sep. 2024 )
	=	(41.781	-	41.793)	/	41.781
	=	-0.03%

Zenas BioPharma Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Zenas BioPharma's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Zenas BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zenas BioPharma Inc (NAS:ZBIO) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

N/A

Address

852 Winter Street, Suite 250, Waltham, MA, USA, 02451

Website

https://www.zenasbio.com

Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.